| Health Net Comm & Medi-Cal Plan | Transcranial Magnetic Stimulation | 2025-04-01 |
| HealthPartners | Advanced drug therapy for pulmonary hypertension: | 2025-04-01 |
| HealthPartners | Crizanlizumab-tmca (Adakveo®) – Minnesota Health | 2025-04-01 |
| HealthPartners | Golodirsen (Vyondys 53®) | 2025-04-01 |
| HealthPartners | Golodirsen (Vyondys 53®) – Minnesota Health Care | 2025-04-01 |
| HealthPartners | Lifileucel (Amtagvi™) | 2025-04-01 |
| HealthPartners | Oncology - atezolizumab (Tecentriq®) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology - avelumab (Bavencio®) – Minnesota Health | 2025-04-01 |
| HealthPartners | Oncology - enfortumab vedotin-ejfv (Padcev™) – | 2025-04-01 |
| HealthPartners | Oncology - luspatercept-aamt (Reblozyl®) | 2025-04-01 |